Encapsys®, the microencapsulation division of Appleton Papers, has entered into an exclusive strategic partnership with Troy Corp., Florham Park, NJ, to develop and supply a microencapsulated biocide to select marketplaces worldwide.

APPLETON, WI – Encapsys®, the microencapsulation division of Appleton Papers, has entered into an exclusive strategic partnership with Troy Corp., Florham Park, NJ, to develop and supply a microencapsulated biocide to select marketplaces worldwide.

Microencapsulation is the process in which solid, liquid or gaseous core materials are encased in “shells” or “capsules” that are one micron to several hundred microns in diameter. Among the many benefits of microencapsulation is the controlled release of a core material. Through microencapsulation, Encapsys scientists were able to control the antimicrobial activity of a biocide to be used in paints, architectural coatings and mortar formulations.